Comparative study of graft-versus-host disease in HLA identical sibling cord blood or bone marrow transplant in children.

被引:0
|
作者
Rocha, V
Wagner, J
Sobocinski, K
Horowitz, M
Gluckman, E
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2822
引用
收藏
页码:685A / 685A
页数:1
相关论文
共 50 条
  • [21] Absence of graft-versus-host disease in the isolated vascularized bone marrow transplant
    Tai, CY
    Strande, LF
    Eydelman, R
    Sheng, XL
    vanTran, JL
    Matthews, MS
    Hewitt, CW
    TRANSPLANTATION, 2004, 77 (02) : 316 - 319
  • [22] PREDICTORS OF ACUTE GRAFT-VERSUS-HOST DISEASE IN BONE-MARROW TRANSPLANTATION BETWEEN HLA-IDENTICAL SIBLINGS
    JOHNSEN, HE
    NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (20): : 1497 - 1497
  • [23] PREDICTIVE FACTORS FOR ACUTE GRAFT-VERSUS-HOST DISEASE IN PATIENTS TRANSPLANTED WITH HLA-IDENTICAL BONE-MARROW
    BROSS, DS
    TUTSCHKA, PJ
    FARMER, ER
    BESCHORNER, WE
    BRAINE, HG
    MELLITS, ED
    BIAS, WB
    SANTOS, GW
    BLOOD, 1984, 63 (06) : 1265 - 1270
  • [24] HEMATOPOIETIC PROGENITOR-CELL FUNCTION AFTER HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTATION - INFLUENCE OF CHRONIC GRAFT-VERSUS-HOST DISEASE
    ATKINSON, K
    NORRIE, S
    CHAN, P
    ZEHNWIRTH, B
    DOWNS, K
    BIGGS, J
    INTERNATIONAL JOURNAL OF CELL CLONING, 1986, 4 (03): : 203 - 220
  • [25] Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate
    Y Kanda
    K Izutsu
    H Hirai
    H Sakamaki
    T Iseki
    Y Kodera
    S Okamoto
    H Mitsui
    K Iwato
    N Hirabayashi
    T Furukawa
    A Maruta
    M Kasai
    Y Atsuta
    N Hamajima
    A Hiraoka
    K Kawa
    Leukemia, 2004, 18 : 1013 - 1019
  • [26] Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate
    Kanda, Y
    Izutsu, K
    Hirai, H
    Sakamaki, H
    Iseki, T
    Kodera, Y
    Okamoto, S
    Mitsui, H
    Iwato, K
    Hirabayashi, N
    Furukawa, T
    Maruta, A
    Kasai, M
    Atsuta, Y
    Hamajima, N
    Hiraoka, A
    Kawa, K
    LEUKEMIA, 2004, 18 (05) : 1013 - 1019
  • [27] PREDICTIVE STRENGTH OF MIXED LYMPHOCYTE-CULTURES FOR ACUTE GRAFT-VERSUS-HOST DISEASE IN PATIENTS TRANSPLANTED WITH HLA-IDENTICAL SIBLING BONE-MARROW
    PAWELEC, G
    MULLER, C
    EHNINGER, G
    TRANSPLANTATION, 1989, 48 (05) : 890 - 891
  • [28] Cyclosporine versus cyclosporine plus methotrexate for the prophylaxis of graft-versus-host disease after HLA-identical sibling bone marrow transplantation for hematologic malignancies randomized prospective study.
    Lee, KH
    Choi, SJ
    Lee, JH
    Kim, S
    Lee, YS
    Seol, M
    Kim, WK
    Lee, JS
    Lee, JH
    BLOOD, 2003, 102 (11) : 439B - 439B
  • [29] Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations
    Oh, H
    Loberiza, FR
    Zhang, MJ
    Ringdén, O
    Akiyama, H
    Asai, T
    Miyawaki, S
    Okamoto, S
    Horowitz, MM
    Antin, JH
    Bashey, A
    Bird, JM
    Carabasi, MH
    Fay, JW
    Gale, RP
    Giller, RH
    Goldman, JM
    Hale, GA
    Harris, RE
    Henslee-Downey, J
    Kolb, HJ
    Litzow, MR
    McCarthy, PL
    Neudorf, SM
    Serna, DS
    Socié, G
    Tiberghien, P
    Barrett, AJ
    BLOOD, 2005, 105 (04) : 1408 - 1416
  • [30] MEMBRANOUS NEPHROPATHY WITH GRAFT-VERSUS-HOST DISEASE IN A BONE-MARROW TRANSPLANT RECIPIENT
    BARBARA, JAJ
    THOMAS, AC
    SMITH, PS
    GILLIS, D
    HO, JOK
    WOODROFFE, AJ
    CLINICAL NEPHROLOGY, 1992, 37 (03) : 115 - 118